Dracen Pharmaceuticals


Data by 
Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients.
Rankings by

National Ranking17517th
in United States Regional Ranking19039th
in North America Global Ranking40529th
worldwide